Point72 Asset Management, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share (CTMX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share
Symbol
CTMX
Shares outstanding
162,743,000 shares
Disclosed Ownership
4,068,575 shares
Ownership
2.5%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:08:10 UTC
Date of event
30 Sep 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 2.5% 4,068,575 0 4,068,575 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 2.5% 4,068,575 0 4,068,575 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 2.5% 4,068,575 0 4,068,575 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person